Carlo Gambacorti-Passerini

34PUBLICATIONS
144CO-AUTHORS
Haematological tumoursRespiratory diseasesMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 24, 2026
Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

|May 14, 2026
Circular RNA in chronic myeloid leukemia.

|Apr 08, 2026
An Uncommon Presentation of Sweet's Syndrome in Primary Myelofibrosis.

Valentina Rago, Valeria Brogna, Fabrizio Cavalca

|Jul 24, 2025
Reconstructing CML guidelines for first line treatment from two different points of view.

Carlo Gambacorti-Passerini, Giulia Bassi, Stefano Bonfanti

|Jun 27, 2025
Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing-Neel Syndrome.

Anna Maria Frustaci, Arianna Zappaterra, Gloria Turri

|Jun 23, 2025
Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITY.

Michael J Mauro, Rüdiger Hehlmann, Loretta A Williams

Pageof 6

Frequent Collaborators

8 joint publications

Rocco Piazza

6 joint publications

Diletta Fontana

4 joint publications

Luca Mologni

4 joint publications

Ivan Civettini